Poster Submission Requirements and Information

 

Poster Abstract Submission Deadline: December 18, 2026

Participate in IO360° poster sessions to showcase your research in a visually engaging and informal setting. This is an excellent opportunity to connect with others interested in immuno-oncology research and to explore potential collaborations. All immuno-oncology related research is welcome for submission. 

 

Poster Session Submission Deadline and Criteria 

How to submit: 
Email the information below to [email protected] and include “IO360° Poster Session Abstract Submission” in the subject line. 
 

 

Criteria for Abstract Submission 

  • Abstracts must focus on scientific questions, clinical observations, primary scientific data, research findings, or other data-driven insights relevant to immuno-oncology. 

  • Submissions from commercial organizations, vendors, and service providers are welcome when supported by scientific data. Submissions may include research findings, validation data, clinical or translational data, case-study data, or other substantive evidence. Abstracts and posters must remain scientific and educational in nature and may not be used primarily to promote a company, product, platform, or service. Company affiliation may be identified as appropriate, but promotional company logos and marketing claims should not be included. 

  • Submissions may be made by an author or designated representative of the participating organization. When applicable, presentation by the first author, a scientific or clinical researcher, or a non-commercial research partner is highly recommended. 

  • An individual or organization may submit up to two abstracts. If both are accepted, an alternate presenter must be appointed for one of the posters. 

  • No revisions to abstracts will be allowed after the submission deadline. 

Late-Breaking Submission Criteria 

Late-breaking submissions are allowed if they meet one of the following criteria: 

  • Results from large-scale phase II or III trials not available by the main deadline (Dec 18). 

  • Groundbreaking findings that could significantly impact current practices. 

 

To submit late-breaking data, provide a placeholder abstract by Jan 29, 2027, including: 

  • All authors and their disclosures 

  • Background and methods sections 

  • Main clinical endpoint for your analysis 

  • Type of analysis, planned analysis date, and statistical methods 

Submission Requirements

  • Author Information: List full names, degrees, institutions/organizations, locations, and email addresses for all authors. Please identify a primary contact for all future correspondence. Up to 20 authors per abstract. 

  • Research Identification: Indicate if your abstract reports on original research or a clinical trial. For clinical trials, if already registered, provide the registry name and trial number. Registration is not required for submission but may be necessary by law for publication. 

  • Funding & Disclosures: Specify the funding source for the abstract, including any secondary sources. All authors must disclose financial ties with for-profit healthcare companies, which will be included in the meeting materials. 

  • Abstract Title and Content: Provide a title that doesn’t reveal the study’s results or conclusions. Include background, methods, results, and conclusions in a PDF (max 2700 characters), with one data table (up to 12 rows) and no figures or illustrations. Title edits may be suggested by the IO360° Poster Review Committee. 

  • Drug Name Usage: Only generic drug names may be used in the abstract and poster. Proprietary or brand drug names and trademark symbols should not be included. 

Poster Session Rates and Benefits 

Industry Rate: $3,500 

  • Includes a speaker pass for the first author to the 3-day event 

  • Access to partnering tool and networking for the first author 

  • A 5-minute pre-recorded video and up to 5 slides will be shared with all IO360° attendees post-event and will be available on the website for 6 months. 

  • Author(s) listed on digital and onsite materials as a Poster Participant 

Academia & Non-profit Rate: $1,995 

  • Includes a speaker pass for the first author to the 3-day event 

  • Access to partnering tool and networking for the first author 

  • A 5-minute pre-recorded video and up to 5 slides will be shared with all IO360° attendees post-event and will be available on the website for 6 months. 

  • Author(s) listed on digital and onsite materials as a Poster Participant 

Important Dates: 

December 18, 2026  Final deadline for all abstract submissions  
February 19, 2027  Last day to withdraw abstracts  

 

Withdrawal Policy 

Requests for withdrawals BEFORE February 19, 2027: 
A full refund will be provided less a $200 administrative fee. Alternatively, you may transfer your submission to attend IO360° without presenting a poster, with access to networking and the option to bring a second author. 

Requests for withdrawals AFTER February 19, 2027: 
Requests must be submitted by the designated poster contact. Your benefits will include attending the conference and networking opportunities. If you cannot attend IO360°, your pass may be transferred to another author or colleague on your team. Alternatively, you may choose to receive full credit toward a future IO360° event. Withdrawals made after February 19, 2027, will not be eligible for refunds. 

*IO360° does not offer Continuing Education Credits